These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 26279177)

  • 1. An audience with...Gloria Maldonado.
    Maldonado G; Mullard A
    Nat Rev Drug Discov; 2015 Sep; 14(9):596. PubMed ID: 26279177
    [No Abstract]   [Full Text] [Related]  

  • 2. Prescription for an ailing pharmaceutical industry.
    Demain AL
    Nat Biotechnol; 2002 Apr; 20(4):331. PubMed ID: 11923826
    [No Abstract]   [Full Text] [Related]  

  • 3. Coming back to life Montreal.
    Hoag H
    Nature; 2004 Jul; 430(6996):274-5. PubMed ID: 15241427
    [No Abstract]   [Full Text] [Related]  

  • 4. From basic research to product development: not an easy way.
    Moncayo A
    Infect Genet Evol; 2003 Sep; 3(3):157-8. PubMed ID: 14522178
    [No Abstract]   [Full Text] [Related]  

  • 5. A status report on neuroscience research, without grade inflation.
    Johnston SC; Hauser SL
    Ann Neurol; 2006 Dec; 60(6):A9-11. PubMed ID: 17192939
    [No Abstract]   [Full Text] [Related]  

  • 6. Rediscovering plant-based drugs.
    Littleton J; Falcone D; Davies HM
    Nat Biotechnol; 2003 Aug; 21(8):843-4. PubMed ID: 12894188
    [No Abstract]   [Full Text] [Related]  

  • 7. India's budget keeps dream of genomics hub alive.
    Padma TV
    Nature; 2016 Mar; 531(7592):16-7. PubMed ID: 26935674
    [No Abstract]   [Full Text] [Related]  

  • 8. HGS drug flop latest genomics setback.
    Reid B
    Nat Biotechnol; 2002 Jun; 20(6):533. PubMed ID: 12042841
    [No Abstract]   [Full Text] [Related]  

  • 9. Curagen sets precedent in post genomics era.
    Fletcher L
    Nat Biotechnol; 2001 Mar; 19(3):186-7. PubMed ID: 11231517
    [No Abstract]   [Full Text] [Related]  

  • 10. An audience with... Nic Jones. Interview by Asher Mullard.
    Jones N
    Nat Rev Drug Discov; 2011 Apr; 10(4):252. PubMed ID: 21455228
    [No Abstract]   [Full Text] [Related]  

  • 11. What's fueling the biotech engine?
    Aggarwal S
    Nat Biotechnol; 2007 Oct; 25(10):1097-104. PubMed ID: 17921989
    [No Abstract]   [Full Text] [Related]  

  • 12. Merck opts for shake-up to clear drug pipeline.
    Nature; 2005 Dec; 438(7071):1076-7. PubMed ID: 16371975
    [No Abstract]   [Full Text] [Related]  

  • 13. Is there a crisis of accountability in the American research university?
    Smith BL; Korn D
    Minerva; 2000; 38(2):129-45. PubMed ID: 17152687
    [No Abstract]   [Full Text] [Related]  

  • 14. Recruiters and industry.
    Jackson M
    Nature; 2004 Mar; 428(6981):450. PubMed ID: 15042100
    [No Abstract]   [Full Text] [Related]  

  • 15. Defining innovation.
    Hughes B
    Nat Rev Drug Discov; 2009 Sep; 8(9):683-4. PubMed ID: 19721435
    [No Abstract]   [Full Text] [Related]  

  • 16. Growth industry.
    Lewis R
    Nature; 2004 Mar; 428(6980):348-9. PubMed ID: 15029202
    [No Abstract]   [Full Text] [Related]  

  • 17. How many genomics targets can a portfolio afford?
    Betz UA
    Drug Discov Today; 2005 Aug; 10(15):1057-63. PubMed ID: 16055022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deal watch: Trends in platform technology deal-making.
    Walker J; Jacob J
    Nat Rev Drug Discov; 2009 Dec; 8(12):923. PubMed ID: 19949395
    [No Abstract]   [Full Text] [Related]  

  • 19. Aligning pharmaceutical innovation with medical need.
    Nathan C
    Nat Med; 2007 Mar; 13(3):304-8. PubMed ID: 17342145
    [No Abstract]   [Full Text] [Related]  

  • 20. Market watch: Therapeutic area 'heat map' for emerging markets.
    Gautam A; Li L; Srinivasan K
    Nat Rev Drug Discov; 2015 Aug; 14(8):518-9. PubMed ID: 26160486
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.